Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Lambert

Showing results (161-170 of 164) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 164 results.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 29, 2017
Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxisDarrell H S Tan, Mark W Hull, Deborah Yoong, et al.
Atherosclerosis|May 15, 2023
Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis SocietyFlorian Kronenberg, Samia Mora, Erik S G Stroes, et al.
European Heart Journal|August 29, 2022
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statementFlorian Kronenberg, Samia Mora, Erik S G Stroes, et al.
Circulation. Cardiovascular Genetics|September 17, 2015
Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal AntibodyPaul N Hopkins, Joep Defesche, Sigrid W Fouchier, et al.
Pageof 17

Showing results (161-170 of 164) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 164 results.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 29, 2017
Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxisDarrell H S Tan, Mark W Hull, Deborah Yoong, et al.
Atherosclerosis|May 15, 2023
Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis SocietyFlorian Kronenberg, Samia Mora, Erik S G Stroes, et al.
European Heart Journal|August 29, 2022
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statementFlorian Kronenberg, Samia Mora, Erik S G Stroes, et al.
Circulation. Cardiovascular Genetics|September 17, 2015
Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal AntibodyPaul N Hopkins, Joep Defesche, Sigrid W Fouchier, et al.
Pageof 17